1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) 2020 Fall Meeting (Day 2)"}],["$","meta","1",{"name":"description","content":"On November 9-10, 2020, NIH will be hosting a virtual meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC). The NExTRAC provides recommendations to the NIH Director and serves as a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. The meeting will include (1) a workshop to examine existing biosafety guidance for contained gene drive research and to discuss potential conditions under which NIH could consider supporting field release of gene drive- modified organisms and (2) discussion of a draft report conceptualizing a framework for NExTRAC deliberation of issues surrounding emerging biotechnologies.

For more information go to https://osp.od.nih.gov/biotechnology/main-nextrac"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) 2020 Fall Meeting (Day 2)"}],["$","meta","4",{"property":"og:description","content":"On November 9-10, 2020, NIH will be hosting a virtual meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC). The NExTRAC provides recommendations to the NIH Director and serves as a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. The meeting will include (1) a workshop to examine existing biosafety guidance for contained gene drive research and to discuss potential conditions under which NIH could consider supporting field release of gene drive- modified organisms and (2) discussion of a draft report conceptualizing a framework for NExTRAC deliberation of issues surrounding emerging biotechnologies.

For more information go to https://osp.od.nih.gov/biotechnology/main-nextrac"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/be63d93c-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/3d72b83b-aa29-45c4-a053-848a0b701f51.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) 2020 Fall Meeting (Day 2)"}],["$","meta","11",{"name":"twitter:description","content":"On November 9-10, 2020, NIH will be hosting a virtual meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC). The NExTRAC provides recommendations to the NIH Director and serves as a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. The meeting will include (1) a workshop to examine existing biosafety guidance for contained gene drive research and to discuss potential conditions under which NIH could consider supporting field release of gene drive- modified organisms and (2) discussion of a draft report conceptualizing a framework for NExTRAC deliberation of issues surrounding emerging biotechnologies.

For more information go to https://osp.od.nih.gov/biotechnology/main-nextrac"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}